Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Novel inhaled combination powders for respiratory infections
- In: APSA EARLY CAREER RESEARCHER SYMPOSIUM on Tuesday, 15 April 2014, 16:00-17:30
- At: PSWC, Melbourne (Australia) (2014)
- Type: Presentation
- By: ZHOU, Qi (Tony) (The University of Sydney, Faculty of Pharmacy, Sydney, Australia)
- Co-author(s): Gengenbach, Thomas (CSIRO Materials Science and Engineering, Melbourne, Australia)
Denman, John (University of South Australia, Adelaide, Australia)
Yu, Heidi (Monash University, Melbourne, Australia)
Li, Jian (Monash University, Melbourne, Australia)
Chan, Hak-Kim (The University of Sydney, Sydney, Australia) - Abstract:
Background: For many respiratory infections caused by multidrug-resistant Gram-negative bacteria, colistin is the only effective antibiotics despite its nephrotoxicity. Inhaled therapy of colistin with a synergistic antimicrobial component of rifampicin may offer better therapeutic efficacy and reduce adverse effects.
Aims: To develop a novel.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023